Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:IBM_Watson_for_Cloud_Services
|
| gptkbp:acquired |
gptkb:Actavis
|
| gptkbp:acquisition |
gptkb:2012
focus on specialty pharmaceuticals |
| gptkbp:ceo |
gptkb:Paul_Bisaro
|
| gptkbp:community_involvement |
gptkb:Educational_Institution
mental health awareness mentorship programs patient advocacy research funding disaster relief efforts environmental sustainability health fairs healthcare initiatives scholarships for students public health campaigns charitable donations health education workshops employee volunteer programs support for local businesses partnerships with non-profits |
| gptkbp:employees |
approximately 5,000
|
| gptkbp:focus |
generic and specialty pharmaceuticals
|
| gptkbp:founded |
gptkb:1985
|
| gptkbp:headquarters |
gptkb:Parsippany,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Watson for Pharmaceuticals
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:market |
global
|
| gptkbp:parent_company |
gptkb:Company
|
| gptkbp:partnerships |
various healthcare organizations
|
| gptkbp:products |
generic drugs
branded drugs |
| gptkbp:research |
gptkb:Dr._David_H._H._Hwang
|
| gptkbp:research_areas |
gptkb:Company
oncology central nervous system infectious diseases pain management women's health respiratory diseases urology gastroenterology cardiovascular |
| gptkbp:revenue |
$3.5 billion (2012)
|
| gptkbp:services |
contract manufacturing
|
| gptkbp:subsidiary |
gptkb:Actavis,_Inc.
|
| gptkbp:traded_on |
NYSE: WPI
|